Thiogenesis Therapeutics, Corp.
TTI.V
TSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/2/2025
-
Simply Wall St
11/2/2025
-
MarketBeat
11/1/2025
-
MarketBeat
11/1/2025
-
Tickeron - Technical Analysis
10/31/2025
-
Simply Wall St
10/31/2025
-
Tickeron - Stocks
10/30/2025
-
GuruFocus
10/30/2025
-
MarketBeat
10/30/2025
-
GuruFocus
10/30/2025
-
The Fly
10/30/2025
-
Simply Wall St
10/30/2025
-
Tickeron - Stocks
10/30/2025
-
Tickeron - Stocks
10/30/2025
-
TipRanks Financial Blog
10/30/2025
-
SeekingAlpha
10/30/2025
-
TipRanks Financial Blog
10/29/2025
-
MarketBeat
10/29/2025
-
The Fly
10/29/2025
-
Seeking Alpha: Transcripts
10/29/2025
-
SeekingAlpha
10/29/2025
-
GuruFocus
10/29/2025
-
TipRanks Financial Blog
10/29/2025
-
Zacks Investment Research
10/29/2025
-
GuruFocus
10/29/2025
-
GuruFocus
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 18, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888-223-9165
Address
4 King Street West
Toronto, ON M5H 1B6
Toronto, ON M5H 1B6
Country
Year Founded
--
Business Description
Sector
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is...
more